Outlook Therapeutics Inc. (NASDAQ: OTLK) Stock Information | RedChip

Outlook Therapeutics Inc. (NASDAQ: OTLK) Listen to this Section


$7.69
+0.0100 ( +0.13% ) 197.7K

Outlook Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing ONS-5010, a monoclonal antibody, or mAb, for various ophthalmic indications.

Market Data


Open


$7.69

Previous close


$7.68

Volume


197.7K

Market cap


$180.46M

Day range


$7.48 - $8.06

52 week range


$4.00 - $29.20

Insider Ownership Transactions

Total Amount Purchased: -1,974,833.00 | $ -15,186,465.77

Date Type Amount Purchased Purchaser
2024-03-08 Sale -94441.00 Auffarth Gerd
2024-03-08 Sale -94441.00 Gangolli Julian S
2024-03-08 Sale -94441.00 Haddadin Yezan Munther
2024-03-08 Sale -94441.00 HILZINGER KURT J
2024-03-08 Sale -94441.00 THURMAN RANDY H
2023-10-06 Sale -370282.00 Gangolli Julian S
2023-10-05 Sale -191113.00 Huang Andong
2023-10-05 Sale -210225.00 Auffarth Gerd
2023-10-05 Sale -358337.00 Haddadin Yezan Munther
2023-10-05 Sale -372671.00 Sukhtian Faisal Ghiath

SEC Fillings


Form Type Description Pages Date
4 Insider transactions 1 Apr 17, 2024
8-k 8K-related 13 Apr 15, 2024
8-k 8K-related 16 Apr 12, 2024
8-k 8K-related 13 Apr 02, 2024
4 Insider transactions 1 Mar 29, 2024
8-k 8K-related 13 Mar 26, 2024
4 Insider transactions 1 Mar 22, 2024
4 Insider transactions 1 Mar 22, 2024
4 Insider transactions 1 Mar 22, 2024
4 Insider transactions 1 Mar 20, 2024

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.